Aerpio Pharmaceuticals, Inc. (ARPO) News

Aerpio Pharmaceuticals, Inc. (ARPO): $33.00

-0.30 (-0.90%)

POWR Rating

Component Grades













Add ARPO to Watchlist
Sign Up

Industry: Biotech


of 508

in industry

Filter ARPO News Items

ARPO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ARPO News Highlights

  • ARPO's 30 day story count now stands at 5.
  • Over the past 15 days, the trend for ARPO's stories per day has been choppy and unclear. It has oscillated between 2 and 3.
  • The most mentioned tickers in articles about ARPO are ALTA, MTOR and ROCK.

Latest ARPO News From Around the Web

Below are the latest news stories about Aerpio Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARPO as an investment opportunity.

Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement

LOS ANGELES, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Aadi) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced the closing of its previously announced merger with Aerpio Pharmaceuticals, Inc. (previously traded on the Nasdaq Capital Market under ARPO).

Intrado Digital Media | August 26, 2021

Earnings Report: Heres what to expect from Aerpio Pharmaceuticals (NASDAQ:ARPO)

Earnings results for Aerpio Pharmaceuticals , Analyst Opinion on Aerpio Pharmaceuticals , Earnings and Valuation of (NASDAQ:ARPO), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Earnings Report: Heres what to expect from Aerpio Pharmaceuticals (NASDAQ:ARPO) appeared first on .

Stock Market Daily | August 11, 2021

Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update

CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (Aerpio) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended June 30, 2021 and provided a business update.

Intrado Digital Media | August 11, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | July 12, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | July 10, 2021

Penny Stock Aerpio Pharmaceuticals’ Merger With Aadi Makes It A Buy, Says Analyst

Aerpio Pharmaceuticals (ARPO) is a biopharmaceutical company focused on developing compounds that activate Tie2. Tie2 is considered a key regulator of vascular stability, and ARPO “believes that activation of Tie2 may have therapeutic potential” for different indications. In Q1, ARPO did not earn any revenues, but net loss widened to $4.4 million from $3.9 million in the same quarter a year ago. Aerpio’s operating expenses increased 36.7% year-over-year to $5.6 million in Q1. The company had cash and cash equivalents of $39 million as of March 31. Merger with Aadi Bioscience In May, Aerpio announced the merger with Aadi Bioscience.

Shrilekha Pethe on TipRanks | July 9, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning, investor!

William White on InvestorPlace | July 9, 2021

ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring

Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company's shares a boost today.

William White on InvestorPlace | July 8, 2021

DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today

Digital Brands (DBGI) stock is rocketing higher on Thursday after revealing estimated financial data for its upcoming quarter.

William White on InvestorPlace | July 8, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds SPRT, FI, NETE, and ARPO Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | July 8, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5065 seconds.